Nemaura Medical Inc
OTC:NMRD

Watchlist Manager
Nemaura Medical Inc Logo
Nemaura Medical Inc
OTC:NMRD
Watchlist
Price: 0.0005 USD 150% Market Closed
Market Cap: 20.2k USD

Nemaura Medical Inc
Investor Relations

Nemaura Medical, Inc. operates as a holding company. The company is headquartered in New York City, New York and currently employs 25 full-time employees. The company went IPO on 2014-11-04. The firm is focused on developing sugarBEAT, which is a non-invasive, glucose monitoring system, for use by persons with Type I and Type II diabetes and used to screen pre-diabetic patients. SugarBEAT consists of disposable adhesive skin-patch containing a sensor, which is connected to a rechargeable wireless transmitter.The SugarBEAT works by extracting glucose from the skin into a chamber in the patch that is in direct contact with an electrode-based sensor .The sensor takes a measurement of the glucose reading every five minutes and sends the data by low energy blue tooth to a smart device such as mobile phone (both android and iOS).The data is recorded on the app and can be viewed in real time as well as storing all historic data for later evaluation as desired. The firm's subsidiaries include Region Green Limited.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
Chairman, CEO, President and Principal Financial & Accounting Officer
No Bio Available
Dr. Arash Ghadar
Chief Operating Officer
No Bio Available
Mr. Jay L. Warner
Head of U.S. Commercial Operations
No Bio Available
Mr. Thomas Bendix Mortensen
Head of E.U. Commercial Operations & Marketing
No Bio Available
Ms. Samantha Sanders
Global Head of Digital Programs
No Bio Available

Contacts

Address
NEW YORK
New York City
57 W 57th St
Contacts